CytoSorbents Corporation (CTSO)

[pearsby09]

Third Party, HMO's, Government (Medicaid/Medicare), ect... will not pay for off label use or Bio marker/Surrogate implications. Reimbursement from all entities need to be utilized for Approved Indications and actual Disease states. If the drug is not Formulary approved with Primary or secondary Tier status, then the patient has to pay out of pocket/Cash. Nobody will pay cash for a cytokine attenuation without proper COE/POC/SOC or actual indication. We are years from any form of cancer treatment. Again, sepsis has cytokine reduction status and after years of access...what has that given the shareholder...? Your...Beloved..Pearsby